Acknowledgement
This study was supported by the Brain Research Program through the National Research Foundation (NRF) of Korea, funded by the Ministry of Science, Information & Communication Technology (ICT), and Future Planning (NRF-2016M3C7A1913845, NRF-2016M3C7A1913933). S-.Y.N. received funding from the Basic Science Research Program (NRF-2017R1D1A1A09000520). This present study was supported by Korean National Research Foundation (NRF) grant funded by the Korean Government (MSIP) (Grant no. 2014R1A5A2009936).
References
- Meng G, Zhong X, Mei H. A systematic investigation into aging related genes in brain and their relationship with Alzheimer's disease. PLoS One 2016;11:e0150624. https://doi.org/10.1371/journal.pone.0150624
- Peters R. Ageing and the brain. Postgrad Med J 2006;82:84-8. https://doi.org/10.1136/pgmj.2005.036665
- Colovic MB, Krstic DZ, Lazarevic-Pasti TD, Bondzic AM, Vasic VM. Acetylcholinesterase inhibitors: pharmacology and toxicology. Curr Neuropharmacol 2013;11:315-35. https://doi.org/10.2174/1570159X11311030006
- Burns A, Rossor M, Hecker J, Gauthier S, Petit H, Moller HJ, et al. The effects of donepezil in Alzheimer's disease - results from a multinational trial. Dement Geriatr Cogn Disord 1999;10:237-44. https://doi.org/10.1159/000017126
- Jelic V, Darreh-Shori T. Donepezil: a review of pharmacological characteristics and role in the management of Alzheimer disease. Clin Med Insights Ther 2010;2:771-88.
- Nuri TH, Yee JC, Gupta M, Khan M, Ming LC. A review of Panax ginseng as an herbal medicine. Arch Pharma Pract 2016;7:61-5. https://doi.org/10.4103/2045-080X.183030
- Hwang SH, Shin TJ, Choi SH, Cho HJ, Lee BH, Pyo MK, Lee JH, Kang J, Kim HJ, Park CW, et al. Gintonin, newly identified compounds from ginseng, is novel lysophosphatidic acids-protein complexes and activates G protein-coupled lysophosphatidic acid receptors with high affinity. Mol Cells 2012;33:151-62. https://doi.org/10.1007/s10059-012-2216-z
- Choi SH, Jung SW, Lee BH, Kim HJ, Hwang SH, Kim HK, Hwang SH, Kim HK, Nah SY. Ginseng pharmacology: a new paradigm based on gintonin-lysophosphatidic acid receptor interactions. Front Pharmacol 2015;6:245. https://doi.org/10.3389/fphar.2015.00245
- Nah SY. Gintonin: a novel ginseng-derived ligand that targets G protein-coupled lysophosphatidic acid receptors. Curr Drug Targets 2012;13:1659-64. https://doi.org/10.2174/138945012803529947
- Moon J, Choi SH, Shim JY, Park HJ, Oh MJ, Kim M, Nah SY. Gintonin administration is safe and potentially beneficial in cognitively impaired elderly. Alzheimer Dis Assoc Disord 2018;32:85-7. https://doi.org/10.1097/WAD.0000000000000213
- Pyo MK, Choi SH, Hwang SH, Shin TJ, Lee BH, Lee SM, Lim YH, Kim DH, Nah SY. Novel glycolipoproteins from ginseng. J Ginseng Res 2011;35:92-103. https://doi.org/10.5142/jgr.2011.35.1.092
- Liu L, Duff K. A technique for serial collection of cerebrospinal fluid from the cisterna magna in mouse. J Vis Exp 2008;10:960.
- Cho HJ, Choi SH, Kim HJ, Lee BH, Rhim H, Kim HC, Hwang SH, Nah SY. Bioactive lipids in gintonin-enriched fraction from ginseng. J Ginseng Res 2019;43:209-17. https://doi.org/10.1016/j.jgr.2017.11.006
- Kim DG, Jang M, Choi SH, Kim HJ, Jhun H, Kim HC, Rhim H, Cho IH, Nah SY. Gintonin, a ginseng-derived exogenous lysophosphatidic acid receptor ligand, enhances blood-brain barrier permeability and brain delivery. Int J Biol Macromol 2018;15:1325-37.
- Ohta H, Sato K, Murata N, Damirin A, Malchinkhuu E, Kon J, et al. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors. Mol Pharmacol 2003;64:994-1005. https://doi.org/10.1124/mol.64.4.994
- Hwang SH, Lee BH, Choi SH, Kim HJ, Won KJ, Lee HM, Rhim H, Kim HC, Nah SY. Effects of gintonin on the proliferation, migration, and tube formation of human umbilical-vein endothelial cells: involvement of lysophosphatidic-acid receptors and vascular-endothelial-growth-factor signaling. J Ginseng Res 2016;40:325-33. https://doi.org/10.1016/j.jgr.2015.10.002
- Choi SH, Kim HJ, Cho HJ, Park SD, Lee NE, Hwang SH, Rhim H, Kim HC, Cho IH, Nah SY. Gintonin-mediated release of astrocytic vascular endothelial growth factor protects cortical astrocytes from hypoxia-induced cell damages. J Ginseng Res 2019;43:305-11. https://doi.org/10.1016/j.jgr.2018.05.006
- Jiang S, Xia R, Jiang Y, Wang L, Gao F. Vascular endothelial growth factors enhance the permeability of the mouse blood-brain barrier. PLoS One 2014;9:e86407. https://doi.org/10.1371/journal.pone.0086407
- Hawkins BT, Sykes DB, Miller DS. Rapid, reversible modulation of blood-brain barrier P-glycoprotein transport activity by vascular endothelial growth factor. J Neurosci 2010;30:1417-25. https://doi.org/10.1523/JNEUROSCI.5103-09.2010
- Tonda-Turo C, Origlia N, Mattu C, et al. Current limitations in the treatment Parkinson's and Alzheimer's diseases: state-of-the-art and future perspective of polymeric carriers. Curr Med Chem 2018;25:5755-71. https://doi.org/10.2174/0929867325666180221125759
- Johnson KE, Wilgus TA. Vascular endothelial growth factor and angiogenesis in the regulation of cutaneous wound repair. Adv Wound Care 2014;3:647-61. https://doi.org/10.1089/wound.2013.0517
- Jackson S, Ham RJ, Wilkinson D. The safety and tolerability of donepezil in patients with Alzheimer's disease. Br J Clin Pharmacol 2004;58:1-8. https://doi.org/10.1111/j.1365-2125.2004.01848.x
Cited by
- Effect of the Gintonin-Enriched Fraction on Glucagon-Like-Protein-1 Release vol.26, pp.20, 2021, https://doi.org/10.3390/molecules26206298